Ibio Inc Stock Today
| IBIO Stock | USD 1.90 0.12 6.74% |
Performance6 of 100
| Odds Of DistressOver 69
|
Ibio is selling at 1.90 as of the 23rd of April 2024; that is 6.74 percent increase since the beginning of the trading day. The stock's open price was 1.78. Ibio has more than 69 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Ibio Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of August 2008 | Category Healthcare | Classification Health Care |
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company was incorporated in 2008 and is headquartered in Bryan, Texas. Ibio operates under Biotechnology classification in the United States and is traded on AMEX Exchange. The company has 8.61 M outstanding shares of which 161.74 K shares are currently shorted by private and institutional investors with about 0.02 trading days to cover. More on Ibio Inc
Moving together with Ibio Stock
| 0.66 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.67 | OPT | Opthea | PairCorr |
Moving against Ibio Stock
| 0.56 | GNTA | Genenta Science SpA Downward Rally | PairCorr |
| 0.54 | ANAB | AnaptysBio Financial Report 9th of May 2024 | PairCorr |
| 0.49 | MGTX | MeiraGTx Holdings PLC Financial Report 9th of May 2024 | PairCorr |
| 0.43 | PCRX | Pacira Pharmaceuticals Earnings Call Next Week | PairCorr |
| 0.42 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.41 | ALKS | Alkermes Plc Earnings Call Next Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Ibio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ibio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ibio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman and CEO | Robert Kay | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Ibio report their recommendations after researching Ibio's financial statements, talking to executives and customers, or listening in on Ibio's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ibio Inc. The Ibio consensus assessment is calculated by taking the average forecast from all of the analysts covering Ibio. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Ibio's profitability, liquidity, and operating efficiency, Ibio Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Ibio Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ibio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ibio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ibio's financial leverage. It provides some insight into what part of Ibio's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ibio Inc (IBIO) is traded on NYSE MKT Exchange in USA. It is located in 8800 Health Science Center Parkway, Bryan, TX, United States, 77807-1107 and employs 26 people. Ibio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ibio's market, we take the total number of its shares issued and multiply it by Ibio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ibio Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 8.61 M outstanding shares of which 161.74 K shares are currently shorted by private and institutional investors with about 0.02 trading days to cover.
Ibio Inc currently holds about 33.52 M in cash with (30.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Ibio Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Ibio is $15.33 Million. Roughly 73.0 (percent) of Ibio outstanding shares are held by general public with 0.17 % owned by insiders and only 26.9 pct. by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Ibio Ownership Details
Ibio Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Ibio jumping above the current price in 90 days from now is about 26.41%. The Ibio Inc probability density function shows the probability of Ibio stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 9.4639. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ibio will likely underperform. Moreover, ibio Inc has an alpha of 1.4375, implying that it can generate a 1.44 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Ibio to move above the current price in 90 days from now is about 26.41 (This Ibio Inc probability density function shows the probability of Ibio Stock to fall within a particular range of prices over 90 days) .
Ibio Historical Income Statement
Ibio Inc Income Statement is one of the three primary financial statements used for reporting Ibio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Ibio Inc revenue and expense. Ibio Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Ibio's Other Operating Expenses is very stable compared to the past year. As of the 23rd of April 2024, Research Development is likely to grow to about 12.5 M, while Depreciation And Amortization is likely to drop about 1.1 M. View More FundamentalsIbio Stock Against Markets
Picking the right benchmark for Ibio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ibio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ibio is critical whether you are bullish or bearish towards Ibio Inc at a given time. Please also check how Ibio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ibio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Ibio Corporate Directors
Ibio corporate directors refer to members of an Ibio board of directors. The board of directors generally takes responsibility for the Ibio's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ibio's board members must vote for the resolution. The Ibio board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| John McKey | Independent Director | Profile | |
| Philip Russell | Independent Director | Profile | |
| Glenn Chang | Independent Director | Profile | |
| Seymour Flug | Director | Profile |
How to buy Ibio Stock?
Before investing in Ibio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ibio. To buy Ibio stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ibio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ibio stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ibio Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ibio Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ibio Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Ibio Stock please use our How to Invest in Ibio guide.
Already Invested in Ibio Inc?
The danger of trading Ibio Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ibio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ibio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ibio Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Ibio Stock analysis
When running Ibio's price analysis, check to measure Ibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ibio is operating at the current time. Most of Ibio's value examination focuses on studying past and present price action to predict the probability of Ibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ibio's price. Additionally, you may evaluate how the addition of Ibio to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Ibio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.25) | Revenue Per Share 0.044 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (1.48) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.